ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

ASN / Education & Meetings / Kidney Week /

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: FR-PO080

AKI During Pregnancy: Baseline Characteristics and Long-Term Outcomes

Session Information

Category: Acute Kidney Injury

  • 101 AKI: Epidemiology‚ Risk Factors‚ and Prevention

Authors

  • Hafid, Mistafa, Penn State College of Medicine, Hershey, Pennsylvania, United States
  • Akkari, Abdel-Rauof M., Penn State College of Medicine, Hershey, Pennsylvania, United States
  • Salameh, Omar Khaleel Mohammad, Penn State College of Medicine, Hershey, Pennsylvania, United States
  • Abdulbasit, Muhammad, Penn State College of Medicine, Hershey, Pennsylvania, United States
  • Ghahramani, Nasrollah, Penn State College of Medicine, Hershey, Pennsylvania, United States
Background

Pregnancy-related acute kidney injury (AKI) is a serious public health problem and is an important cause of maternal and fetal morbidity and mortality. The incidence of pregnancy-related AKI has increased due to increase in maternal age and higher detection rates. Using a large multicenter cohort, we analyzed the differences in demographic characteristics in pregnant women who developed AKI during pregnancy with those who did not develop AKI.

Methods

We performed a retrospective multi-center cohort study using TriNetX Research Network database, a federated medical records network, to identify 1,537,027 pregnant women from 46 healthcare organizations (HCOs) in the United States. From this group, we then identified women who has a confirmed diagnosis of AKI during their pregnancy. We calculated the odds ratio (OR) and 95% confidence interval (CI) of diagnosis offend Stage Renal Disease (ESRD) and death in the first five years after pregnancy.

Results

4,867 pregnant women (from 40 HCOs) had a confirmed diagnosis of AKI during pregnancy. Compared with the non-AKI group, women in the AKI group were older (37.9 ± 17.5 vs. 31.4 ± 8.9; p <0.0001) and more likely to:
● be African American (p<0.001)
● have a Body Mass Index (BMI) > 30 kg/m2 (p<0.001)
● have a BMI < 20 kg/m2 (p<0.001)
● be nicotine dependent during pregnancy (p<0.001)

Within the first five years after pregnancy, a total of 4798 women (434 with AKI) were diagnosed with ESRD and 5136 women (550 with AKI) died. After propensity matching, AKI was associated with higher odds of ESRD (OR: 33.6; CI:30.4 to 37.3), and mortality (OR: 41.7; CI: 38.0 to 45.8).

Conclusion

Among pregnant women, those who developed AKI during pregnancy were more likely to be older at time of pregnancy, African American, have a BMI above 30 kg/m2 or below 20 kg/m2 , and to be nicotine dependent during pregnancy. AKI during pregnancy was associated with higher likelihood of ESRD and death within five years after pregnancy.